Your browser doesn't support javascript.
loading
Peptide Vaccination Against PD-L1 With IO103 a Novel Immune Modulatory Vaccine in Multiple Myeloma: A Phase I First-in-Human Trial.
Jørgensen, Nicolai Grønne; Klausen, Uffe; Grauslund, Jacob Handlos; Helleberg, Carsten; Aagaard, Thomas Granum; Do, Trung Hieu; Ahmad, Shamaila Munir; Olsen, Lars Rønn; Klausen, Tobias Wirenfeldt; Breinholt, Marie Fredslund; Hansen, Morten; Martinenaite, Evelina; Met, Özcan; Svane, Inge Marie; Knudsen, Lene Meldgaard; Andersen, Mads Hald.
Afiliação
  • Jørgensen NG; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark.
  • Klausen U; Department of Hematology, Copenhagen University Hospital, Herlev, Denmark.
  • Grauslund JH; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark.
  • Helleberg C; Department of Hematology, Copenhagen University Hospital, Herlev, Denmark.
  • Aagaard TG; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark.
  • Do TH; Department of Hematology, Copenhagen University Hospital, Herlev, Denmark.
  • Ahmad SM; Department of Hematology, Copenhagen University Hospital, Herlev, Denmark.
  • Olsen LR; Department of Hematology, Copenhagen University Hospital, Herlev, Denmark.
  • Klausen TW; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark.
  • Breinholt MF; Department of Health Technology, Technical University of Denmark, Kgs. Lyngby, Denmark.
  • Hansen M; Department of Hematology, Copenhagen University Hospital, Herlev, Denmark.
  • Martinenaite E; Department of Pathology, Copenhagen University Hospital, Herlev, Denmark.
  • Met Ö; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark.
  • Svane IM; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark.
  • Knudsen LM; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark.
  • Andersen MH; Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.
Front Immunol ; 11: 595035, 2020.
Article em En | MEDLINE | ID: mdl-33240282
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Peptídeos / Ácidos Oleicos / Vacinas Anticâncer / Antígeno B7-H1 / Manitol / Mieloma Múltiplo / Proteínas de Neoplasias Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Front Immunol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Dinamarca
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Peptídeos / Ácidos Oleicos / Vacinas Anticâncer / Antígeno B7-H1 / Manitol / Mieloma Múltiplo / Proteínas de Neoplasias Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Front Immunol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Dinamarca